Advertisement
Advertisement
U.S. markets close in 1 minute
Advertisement
Advertisement
Advertisement
Advertisement

Calithera Biosciences, Inc. (CALA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.4501-0.0739 (-14.10%)
As of 03:59PM EST. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close0.5240
Open0.5146
Bid0.4582 x 1200
Ask0.4583 x 800
Day's Range0.4473 - 0.5190
52 Week Range0.4473 - 3.3350
Volume2,872,746
Avg. Volume1,996,524
Market Cap33.724M
Beta (5Y Monthly)1.51
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for CALA

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Calithera Biosciences, Inc.
    NKTR: What does Argus have to say about NKTR?NEKTAR THERAPEUTICS has an Investment Rating of HOLD; a target price of $13.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
    Rating
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more
All
News
Press Releases
Advertisement
Advertisement